Mary K Estes Selected Research

Gastroenteritis

1/2022	Novel fold of rotavirus glycan-binding domain predicted by AlphaFold2 and determined by X-ray crystallography.
12/2021	Dasabuvir Inhibits Human Norovirus Infection in Human Intestinal Enteroids.
1/2020	Genetic Manipulation of Human Intestinal Enteroids Demonstrates the Necessity of a Functional Fucosyltransferase 2 Gene for Secretor-Dependent Human Norovirus Infection.
1/2020	Human norovirus exhibits strain-specific sensitivity to host interferon pathways in human intestinal enteroids.
1/2019	GII.4 Norovirus Protease Shows pH-Sensitive Proteolysis with a Unique Arg-His Pairing in the Catalytic Site.
1/2018	Viral gastroenteritis.
5/2017	B-Cell Responses to Intramuscular Administration of a Bivalent Virus-Like Particle Human Norovirus Vaccine.
1/2017	Human Sera Collected between 1979 and 2010 Possess Blocking-Antibody Titers to Pandemic GII.4 Noroviruses Isolated over Three Decades.
9/2015	Structural basis of glycan specificity in neonate-specific bovine-human reassortant rotavirus.
8/2015	Serological Correlates of Protection against a GII.4 Norovirus.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mary K Estes Research Topics

Disease

69	Infections 11/2022 - 01/2002
25	Gastroenteritis 01/2022 - 03/2002
21	Rotavirus Infections 12/2019 - 01/2002
12	Caliciviridae Infections 11/2022 - 06/2005
12	Virus Diseases (Viral Diseases) 02/2022 - 06/2002
11	Diarrhea 01/2021 - 10/2005
3	Biliary Atresia 11/2013 - 09/2011
2	Respiratory Syncytial Virus Infections 02/2022 - 07/2021
2	Chronic Disease (Chronic Diseases) 01/2022 - 10/2017
2	Inflammation (Inflammations) 01/2020 - 01/2020
2	Reinfection 11/2017 - 07/2011
2	Human Influenza (Influenza) 01/2017 - 11/2015
2	Vomiting 11/2015 - 03/2015
2	Viremia 06/2010 - 05/2006
1	Common Variable Immunodeficiency 11/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 10/2021
1	Mental Disorders (Mental Disorder) 01/2021
1	Ulcerative Colitis 01/2021
1	Crohn Disease (Crohn's Disease) 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Neoplasms (Cancer) 01/2021
1	Obesity 01/2021
1	Coinfection 01/2020
1	Substance-Related Disorders (Drug Abuse) 01/2019

Drug/Important Bio-Agent (IBA)

23	VaccinesIBA 10/2022 - 03/2002
23	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2002
12	Blood Group Antigens (Blood Groups)IBA 11/2020 - 05/2002
11	AntigensIBA 02/2015 - 01/2002
10	Polysaccharides (Glycans)IBA 01/2022 - 04/2012
10	Antiviral Agents (Antivirals)IBA 12/2021 - 06/2004
7	InterferonsIBA 11/2022 - 05/2009
7	EnzymesIBA 01/2020 - 01/2002
6	Immunoglobulin A (IgA)IBA 11/2017 - 11/2004
5	AntibodiesIBA 12/2020 - 11/2004
5	Enterotoxins (Enterotoxin)IBA 01/2016 - 04/2007
4	Rotavirus VaccinesIBA 11/2018 - 01/2009
4	Immunoglobulin G (IgG)IBA 05/2017 - 08/2015
4	ImmunosorbentsIBA 07/2011 - 01/2002
3	Monoclonal AntibodiesIBA 02/2022 - 01/2006
3	Pharmaceutical PreparationsIBA 01/2022 - 10/2017
3	CarbohydratesIBA 01/2021 - 06/2004
3	Capsid Proteins (Capsid Protein)IBA 12/2020 - 07/2004
3	Glycoproteins (Glycoprotein)IBA 12/2019 - 03/2008
3	CalciumIBA 01/2019 - 04/2007
3	Attenuated VaccinesIBA 01/2019 - 05/2009
3	LigandsIBA 01/2017 - 10/2005
2	Immunoglobulins (Immunoglobulin)IBA 11/2022 - 07/2011
2	Palivizumab FDA Link 02/2022 - 07/2021
2	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2021 - 01/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2020
2	Neutralizing AntibodiesIBA 12/2020 - 02/2015
2	Serotonin (5 Hydroxytryptamine)IBA 11/2020 - 01/2019
2	Interferon LambdaIBA 01/2020 - 01/2017
2	Bile Acids and Salts (Bile Acids)IBA 01/2020 - 01/2018
2	Interleukin-18 (Interleukin 18)IBA 01/2020 - 11/2014
2	Interleukin-8 (Interleukin 8)IBA 06/2019 - 06/2002
2	OligosaccharidesIBA 11/2018 - 01/2017
2	Biological ProductsIBA 03/2018 - 01/2018
2	Virulence Factors (Pathogenicity Factors)IBA 11/2017 - 12/2014
2	Blocking AntibodiesIBA 05/2017 - 10/2010
2	RNA (Ribonucleic Acid)IBA 10/2016 - 11/2007
2	Viroporin ProteinsIBA 11/2015 - 12/2013
2	RotaTeqIBA 05/2009 - 01/2009
2	RIX4414 vaccineIBA 05/2009 - 01/2009
1	Galectins (Galectin)IBA 01/2022
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 12/2021
1	dasabuvirIBA 12/2021
1	CollagenIBA 11/2021
1	matrigelIBA 11/2021
1	Conditioned Culture MediaIBA 01/2021
1	Dietary Carbohydrates (Carbohydrate, Dietary)IBA 01/2021
1	Dopamine (Intropin)FDA LinkGeneric 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Adenosine Diphosphate (ADP)IBA 11/2020
1	GlycosphingolipidsIBA 11/2020
1	Detergents (Detergent)IBA 01/2020
1	CeramidesIBA 01/2020
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 01/2020
1	MucinsIBA 01/2020
1	Silk FDA Link 01/2020
1	Amino Acids FDA Link 01/2020
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2020
1	Glycochenodeoxycholic Acid (Glycochenodeoxycholate)IBA 01/2020
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2020
1	Galactoside 2-alpha-L-fucosyltransferase (Fucosyltransferase 2)IBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 06/2019
1	GhrelinIBA 01/2019
1	Gastric Inhibitory Polypeptide (Glucose Dependent Insulinotropic Peptide)IBA 01/2019
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2019
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2019
1	Oxytocin (Pitocin)FDA LinkGeneric 01/2019
1	Peptide Hydrolases (Proteases)FDA Link 01/2019
1	Doxycycline (Periostat)FDA LinkGeneric 01/2019
1	Peptide YYIBA 01/2019
1	Hormones (Hormone)IBA 01/2019
1	A 17 (A-17)IBA 01/2018

Therapy/Procedure

5	Therapeutics 12/2021 - 06/2004
2	Liver Transplantation 11/2013 - 01/2012
1	Bariatric Surgery 01/2021
1	Bioreactors (Bioreactor) 01/2021